Cu-Catalyzed Cyclopropanation of Olefins
J . Org. Chem., Vol. 62, No. 8, 1997 2525
161.5, 112.6, 79.6, 74.0, 67.4, 18.1, 27.9, 26.3; IR (neat, cm-1
)
(-)-(4R,5R)-Bis[(S)-4-isop r op yloxa zolin -2-yl]-1,3-d iox-
ola n e (13a ). The ligand 13a was prepared from 12a (0.50 g,
2.47 mmol) and L-valinol (0.56 g, 5.43 mmol) in 78% overall
yield following the same procedure as reported for 6c. Cy-
clization of the intermediate bis-mesylate with KOH required
only 1 day. Purification by flash chromatography (2% CHCl3,
1.5% Et3N in pentane) gave the pure compound as a colorless
3125, 2975, 1675, 1225; MS (EI) m/ z (rel intensity) 316 (M+
- 36, <1), 275 (90), 233 (30), 216 (39), 191 (42), 178 (60), 163
(35), 137 (100), 112 (33), 98 (26), 82 (24), 70 (23). Anal. Calcd
for C15H24N2O4: C, 60.79; H, 8.16; N, 9.45. Found: C, 60.58;
H, 8.09; N, 9.28.
(-)-(4R,5R)-Bis[(S)-4-ben zyloxazolin -2-yl]-2,2-dim eth yl-
1,3-d ioxola n e (6b). The ligand 6b was prepared from 10
(1.00 g, 4.58 mmol) and L-phenylalaninol (1.52 g, 10.1 mmol)
in 84% overall yield (colorless oil) following the same procedure
as reported for 6c: [R]21D ) -82.5 (c ) 1.00, CH2Cl2); 1H NMR
(300 MHz) δ 7.29 (m, 5 H), 7.21 (m, 10 H), 4.91 (s, 2 H), 4.46
(m, 2 H), 4.28 (app t, J ) 9.0 Hz, 2 H), 4.08 (app t, J ) 9.0 Hz,
2 H), 3.14 (dd, J ) 13.8, 5.2 Hz, 2 H), 2.68 (dd, J ) 13.7, 8.5
Hz, 2 H), 1.52 (s, 6 H); 13C NMR (75.5 MHz) δ 163.8, 137.4,
129.1, 128.5, 126.5, 112.8, 73.9, 72.4, 67.3, 41.3, 26.3; IR (neat,
cm-1) 2987, 2935, 1670, 1382, 1248; MS (EI) m/ z (rel intensity)
420 (M+, 34), 405 (14), 329 (72), 271 (41), 260 (20), 243 (33),
202 (40), 117 (54), 91 (100). Anal. Calcd for C25H28N2O4: C,
71.41; H, 6.71; N, 6.66. Found: C, 71.25; H, 6.79; N, 6.58.
oil in 78% yield: [R]21 ) -136.4 (c ) 1.00, CH2Cl2); 1H NMR
D
(400 MHz) δ 5.23 (s, 2 H), 4.94 (d, J ) 1.5 Hz, 2 H), 4.33 (dd,
J ) 9.6, 8.3 Hz, 2 H), 4.05 (app t, J ) 8.2 Hz, 2 H), 3.97 (ddd,
J ) 9.7, 8.1, 6.1 Hz, 2 H), 1.78 (m, 2 H), 0.96 (d, J ) 6.7 Hz,
6 H), 0.89 (d, J ) 6.7 Hz, 6 H); 13C NMR (100.4 MHz) δ 163.1,
127.5, 96.9, 74.0, 72.2, 70.9, 32.4, 18.6, 18.0; IR (CCl4, cm-1
)
2961, 1674; MS (EI) m/ z (rel intensity) 296 (M+, 16), 251 (83),
223 (100), 195 (59), 184 (16), 154 (93), 140 (34), 112 (34), 84
(27), 69 (62). Anal. Calcd for C15H24N2O4: C, 60.79; H, 8.16;
N, 9.45. Found: C, 60.56; H, 7.99; N, 9.23.
(-)-(4R,5R)-Bis[(S)-4-isopr opyloxazolin -2-yl]-2,2-dieth yl-
1,3-d ioxola n e (13b). The ligand 13b was prepared from 12b
(0.28 g, 1.14 mmol) and L-valinol (0.26 g, 2.51 mmol) in 32%
overall yield (pale yellow oil) following the same procedure as
(-)-(4R,5R)-Bis[(S)-4-ter t-bu tyloxa zolin -2-yl]-2,2-d im -
eth yl-1,3-d ioxola n e (6d ). The ligand 6d was prepared from
10 (0.80 g, 3.67 mmol) and L-tert-leucinol (0.95 g, 8.07 mmol)
in 54% overall yield (white solid) following the same procedure
1
reported for 6c: [R]21 ) -106.1 (c ) 1.08, CH2Cl2); H NMR
D
(300 MHz) δ 4.88 (s, 2 H), 4.30 (dd, J ) 9.1, 8.7 Hz, 2 H), 4.04
(app t, J ) 8.4 Hz, 2 H), 3.96 (dd, J ) 9.4, 6.1 Hz, 2 H), 1.75
(m, 6 H), 0.95 (d, J ) 6.7 Hz, 12 H), 0.86 (t, J ) 6.7 Hz, 6 H);
13C NMR (75.5 MHz) δ 162.9, 116.5, 74.3, 72.0, 70.6, 32.4, 29.8,
18.7, 17.9, 7.8; IR (CCl4, cm-1) 2964, 2879, 1673, 1466; MS
(EI) m/ z (rel intensity) 352 (M+, 6), 285 (23), 172 (59), 142
(35), 111 (29), 98 (21), 86 (35), 69 (89). Anal. Calcd for
C19H32N2O4: C, 64.75; H, 9.15; N, 7.95. Found: C, 64.73; H,
8.92; N, 8.05.
as reported for 6c: mp 91-93 °C; [R]21 ) -117.5 (c ) 1.00,
D
CH2Cl2); 1H NMR (300 MHz) δ 4.97 (s, 2 H), 4.26 (dd, J )
10.2, 8.8 Hz, 2 H), 4.15 (app t, J ) 8.5 Hz, 2 H), 3.90 (dd, J )
7.9, 5.7 Hz, 2 H), 1.51 (s, 6 H), 0.88 (s, 18 H); 13C NMR (75.5
MHz) δ 163.2, 112.7, 75.6, 74.0, 69.3, 33.6, 29.4, 25.7; IR (CCl4,
cm-1) 2958, 1675, 1247; MS (EI) m/ z (rel intensity) 337 (M+
- 15, 17), 295 (10), 237 (100), 168 (30), 112 (36), 84 (16). Anal.
Calcd for C19H32N2O4: C, 64.75; H, 9.15; N, 7.95. Found: C,
64.78; H, 9.20; N, 7.87.
(-)-(4R,5R)-Bis[(S)-4-isop r op yloxa zolin -2-yl]-2,2-d ibu -
tyl-1,3-d ioxola n e (13c). The ligand 13c was prepared from
12c (1.00 g, 3.31 mmol) and L-valinol (0.75 g, 7.28 mmol) in
35% overall yield (colorless oil) following the same procedure
as reported for 6c. The methanolic KOH treatment of the bis-
(-)-(4R,5R)-Bis[(S)-4-(1-m et h ylp r op yl)oxa zolin -2-yl]-
2,2-d im eth yl-1,3-d ioxola n e (6e). The ligand 6e was pre-
pared from 10 (0.70 g, 3.21 mmol) and L-isoleucinol (0.83 g,
7.06 mmol) in 50% overall yield (colorless oil) following the
mesylate required 4 days to reach completion: [R]21 ) -40.5
D
1
(c ) 1.26, CH2Cl2); H NMR (400 MHz) δ 4.88 (s, 2 H), 4.32
same procedure as reported for 6c: [R]21 ) -120.9 (c ) 1.12,
D
(dd, J ) 9.7, 8.3 Hz, 2 H), 4.06 (dd, J ) 8.1, 6.7 Hz, 2 H), 3.96
(m, 2 H), 1.74 (m, 4 H), 1.34 (bm, 8 H), 0.97 (m, 6 H), 0.89
(app t, J ) 6.7 Hz, 12 H); 13C NMR (100.4 MHz) δ 116.2, 77.7,
74.2, 72.1, 70.6, 64.2, 57.4, 37.2, 36.8, 32.4, 29.0, 25.8, 25.6,
22.8, 19.5, 18.7, 18.5, 18.0, 14.0; IR (CCl4, cm-1) 2960, 1731,
1273; MS (EI) m/ z (rel intensity) 413 (M+ - 30, 78), 387 (31),
285 (28), 172 (65), 142 (38), 130 (13), 104 (35), 85 (58), 69 (87).
Anal. Calcd for C23H40N2O4: C, 67.61; H, 9.87; N, 6.86.
Found: C, 67.48; H, 10.05; N, 6.65.
CH2Cl2); 1H NMR (300 MHz) δ 4.92 (s, 2 H), 4.28 (m, 2 H),
1.72 (m, 2 H), 1.49 (m, 10 H), 1.15 (dddq, J ) 14.3, 13.9, 7.4,
7.4 Hz, 2 H), 0.89 (t, J ) 7.4 Hz, 6 H), 0.80 (d, J ) 6.8 Hz, 6
H); 13C NMR (75.5 MHz) δ 162.9, 112.6, 74.0, 70.6, 70.2, 38.6,
26.3, 25.9, 14.1, 11.5; IR (neat, cm-1) 2963, 1673, 1382; MS
(EI) m/ z (rel intensity) 352 (M+, 1), 337 (42), 295 (32), 237
(100), 209 (17), 168 (50), 153 (18), 128 (19), 110 (21). Anal.
Calcd for C19H32N2O4: C, 64.75; H, 9.15; N, 7.95. Found: C,
64.66; H, 9.03; N, 7.87.
(-)-(4R,5R)-Bis[(S)-4-isop r op yloxa zolin -2-yl]-2-m eth yl-
1,3-d ioxola n e (13d ). The ligand 13d was prepared from 12d
(1.40 g, 6.86 mmol) and L-valinol (1.56 g, 15.09 mmol) in 34%
overall yield (colorless oil) following the same procedure as
reported for 6c. The methanolic KOH treatment of the bis-
mesylate required 1 day to reach completion: [R]21D ) -147.4
(+)-(4S,5S)-Bis[(S)-4-isop r op yloxa zolin -2-yl]-2,2-d im -
eth yl-1,3-d ioxola n e (7a ). The method described for the
preparation of 6c was also used to prepare the ligands with
D-tartrate backbone. The ligand 7a was prepared from 11
(0.60 g, 2.75 mmol) and L-valinol (0.62 g, 6.05 mmol) in 73%
1
overall yield (colorless oil) following the same procedure as
(c ) 1.25, CH2Cl2); H NMR (400 MHz) δ 5.39 (q, J ) 4.8 Hz,
1
reported for 6c: [R]21 ) -12.7 (c ) 0.99, CH2Cl2); H NMR
D
1 H), 4.90 (m, 2 H), 4.31 (m, 2 H), 4.04 (m, 2 H), 3.96 (m, 2 H),
1.78 (m, 2 H), 1 (m, 3 H), 0.95 (m, 6 H), 0.88 (m, 6 H); 13C
NMR (100.4 MHz) δ 163.6, 163.1, 104.0, 74.7, 74.2, 72.1, 72.0,
(300 MHz) δ 4.96 (s, 2 H), 4.32 (app. t, J ) 9.1 Hz, 2 H), 4.06
(app t, J ) 9.1 Hz, 2 H), 3.98 (ddd, J ) 9.1, 7.6, 6.1 Hz, 2 H),
1.78 (dqq, J ) 14.0, 6.7, 6.5 Hz, 2 H), 1.51 (s, 6 H), 0.95 (d, J
) 6.6 Hz, 6 H), 0.88 (d, J ) 6.7 Hz, 6 H); 13C NMR (75.5 MHz)
δ 163.1, 112.6, 74.1, 72.1, 70.6, 32.3, 26.3, 18.6, 17.8; IR (CCl4,
cm-1) 2960, 1673, 1371, 1242; MS (EI) m/ z (rel intensity) 324
(M+, 11), 309 (57), 281 (19), 267 (24), 223 (100), 195 (23), 154
(80), 114 (55), 85 (49), 69 (39). Anal. Calcd for C17H28N2O4:
C, 62.94; H, 8.70; N, 8.63. Found: C, 63.08; H, 8.66; N, 8.53.
70.9, 70.7, 46.3, 32.4, 29.4, 19.4, 18.7, 18.6, 18.0; IR (CCl4, cm-1
)
2960, 1729, 1675; MS (EI) m/ z (rel intensity) 310 (M+, <1%),
291 (41), 246 (41), 194 (37), 178 (19), 151 (100), 110 (31), 96
(13), 68 (30). Anal. Calcd for C16H26N2O4: C, 61.91; H, 8.44;
N, 9.03. Found: C, 61.95; H, 8.52; N, 9.15.
(-)-(4R,5R)-Bis[(S)-4-isop r op yloxa zolin -2-yl]-2-m eth yl-
2-p h en yl-1,3-d ioxola n e (13e). The ligand 13d was prepared
from 12e (0.60 g, 2.14 mmol) and L-valinol (0.49 g, 4.71 mmol)
in 25% overall yield (colorless oil) following the same procedure
as reported for 6c: [R]21D ) -99.7 (c ) 1.01, CH2Cl2); 1H NMR
(300 MHz) δ 7.54 (m, 2 H), 7.27 (m, 3 H), 5.00 (m, 2 H), 4.34
(m, 1H), 4.05 (m, 2 H), 3.99 (m, 1 H), 3.89 (app t, J ) 8.0 Hz,
1 H), 3.67 (m, 1 H), 1.78 (s, 3 H), 1.60 (m, 2 H), 0.95 (d, J )
6.8 Hz, 3 H), 0.87 (d, J ) 6.8 Hz, 3 H), 0.84 (d, J ) 6.8 Hz, 3
H), 0.76 (d, J ) 6.7 Hz, 3 H); 13C NMR (75.5 MHz) δ 162.6,
142.5, 128.0, 127.8, 125.5, 112.4, 74.4, 73.8, 72.0, 71.8, 70.7,
70.4, 32.4, 32.2, 28.3, 18.6, 18.5, 17., 17.8; IR (CCl4, cm-1) 2873,
1673, 1371; MS (EI) m/ z (rel intensity) 386 (M+, 9%), 371 (23),
327 (100), 223 (15), 105 (22). Anal. Calcd for C22H30N2O4: C,
68.37; H, 7.82; N, 7.25. Found: C, 68.22; H, 7.61; N, 7.09.
(+)-(4S,5S)-Bis[(S)-4-ter t-b u t yloxa zolin -2-yl]-2,2-d im -
eth yl-1,3-d ioxola n e (7b). The ligand 7b was prepared from
11 (0.60 g, 2.75 mmol) and L-tert-leucinol (0.71 g, 6.05 mmol)
in 52% overall yield (white solid) following the same procedure
as reported for 6c: mp 117-119 °C; [R]21 ) -40.8 (c ) 0.98,
D
1
CH2Cl2); H NMR (300 MHz) δ 4.96 (s, 2 H), 4.27 (app t, J )
8.0 Hz, 2 H), 4.14 (app t, J ) 8.0 Hz, 2 H), 3.91 (app t, J ) 8.0
Hz, 2 H), 1.51 (s, 6 H), 0.89 (s, 18 H); 13C NMR (75.5 MHz) δ
162.9, 112.6, 75.8, 74.2, 69.3, 33.6, 26.2, 25.7; IR (CCl4, cm-1
)
2958, 1675, 1365, 1246; MS (EI) m/ z (rel intensity) 337 (M+
- 15, 17), 295 (11), 237 (100), 168 (29), 112 (34), 84 (15). Anal.
Calcd for C19H32N2O4: C, 64.75; H, 9.15; N, 7.95. Found: C,
64.60; H, 9.25; N, 8.03.